Gilead Sciences, Inc.
Imidazopyrimidine Derivatives

Last updated:

Abstract:

The present disclosure provides a compound of Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating cancers.

Status:
Application
Type:

Utility

Filling date:

8 Oct 2021

Issue date:

4 Aug 2022